Glucose >200 mg/dL during Continuous Glucose Monitoring Identifies Adult Patients at Risk for Development of Cystic Fibrosis Related Diabetes

Table 1

Subject demographics at enrollment.

Variable	Enrolled	Complete CFRD testing available
	Age (years)	32.4 SD 13.1	33.8 SD 13.7
Female	76% (16/21)	72% (13/18)
Homozygous for F508del	52% (11/21)	44% (8/18)
At least one copy of F508del	90% (19/21)	89% (16/18)
FEV1 (L)	2.27 SD 0.84	2.23 SD 0.21
FEV1% predicted	68.8 SD 5.5	66.7 SD 6.3
BMI	21.6 SD 0.72	21.9 SD 0.81

There were no significant differences for any of the variables between the two groups.